Financhill
Sell
15

BDTX Quote, Financials, Valuation and Earnings

Last price:
$2.68
Seasonality move :
-28.39%
Day range:
$2.54 - $2.69
52-week range:
$1.20 - $4.94
Dividend yield:
0%
P/E ratio:
7.37x
P/S ratio:
2.18x
P/B ratio:
1.21x
Volume:
1.2M
Avg. volume:
1.5M
1-year change:
21.92%
Market cap:
$152.4M
Revenue:
--
EPS (TTM):
$0.36

Earnings Data

Next earnings date for BDTX
Mar 05
2026
Most recent earnings per share
-$0.15
Beat by $0.08
(Nov 6/2025)
Consensus Estimate
-$0.23
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 -- -- -- -$0.17 --
11/06/2025 Q3 -- -- -$0.15 -$0.23 $0.08
08/07/2025 Q2 -- -- -$0.19 -$0.23 $0.05
05/12/2025 Q1 $17.5M $70M $0.98 -$0.26 $1.24
03/06/2025 Q4 -- -- -$0.28 -$0.31 $0.03
11/05/2024 Q3 -- -- -$0.28 -$0.36 $0.08
08/06/2024 Q2 -- -- -$0.36 -$0.39 $0.03
05/09/2024 Q1 -- -- -$0.35 -$0.43 $0.08
03/12/2024 Q4 -- -- -$0.34 -$0.46 $0.12
11/06/2023 Q3 -- -- -$0.45 -$0.49 $0.04
08/11/2023 Q2 -- -- -$0.52 -$0.52 $0.00
05/09/2023 Q1 -- -- -$0.57 -$0.61 $0.04
03/17/2023 Q4 -- -- -$0.59 -$0.61 $0.02
11/08/2022 Q3 -- -- -$0.60 -$0.62 $0.02
08/09/2022 Q2 -- -- -$0.63 -$0.67 $0.04
05/11/2022 Q1 -- -- -$0.70 -$0.74 $0.04
03/17/2022 Q4 -- -- -$0.71 -$0.98 $0.27
11/08/2021 Q3 -- -- -$0.97 -$0.95 -$0.02
08/12/2021 Q2 -- -- -$0.95 -$0.88 -$0.07
05/07/2021 Q1 -- -- -$0.84 -$0.65 -$0.19
03/25/2021 Q4 -- -- -$0.63 -$0.61 -$0.02
11/10/2020 Q3 -- -- -$0.50 -$0.50 $0.00
08/11/2020 Q2 -- -- -$0.41 -$0.39 -$0.02
05/12/2020 Q1 -- -- -$0.51 -$0.49 -$0.02
03/24/2020 Q4 -- -- -$0.30 -- --
09/30/2019 Q3 -- -- -$0.66 -- --
06/30/2019 Q2 -- -- -$0.88 -- --
03/31/2019 Q1 -- -- -$0.27 -- --
12/31/2018 Q4 -- -- -$0.22 -- --

Black Diamond Therapeutics, Inc. Earnings Questions

  • How Much did Black Diamond Therapeutics, Inc. Generate in Revenue Last Quarter?

    Black Diamond Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Black Diamond Therapeutics, Inc. Beat Earnings Last Quarter?

    Black Diamond Therapeutics, Inc. announced earnings per share of -$0.15 which represents a beat of analyst forecast a -$0.23 per share.

  • Is Black Diamond Therapeutics, Inc. Profitable?

    Black Diamond Therapeutics, Inc. reported -$86K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Black Diamond Therapeutics, Inc. EPS Next Year?

    Black Diamond Therapeutics, Inc.'s earnings are forecast to decrease from -$1.27 per share to -$1.27 per share next year representing a decrease of -54.72%.

  • When is Black Diamond Therapeutics, Inc.'s Earnings Date?

    Black Diamond Therapeutics, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock